Market Overview

Benzinga's Top #PreMarket Gainers

Related AGN
Wall Street's M&A Chatter From December 12: Fox-Disney, Repros Therapeutics-Allergan, Agrium-Macrofertil
Lightning Round: Jim Cramer Shares His Thoughts On Allergan, ETP, Cisco And More
Your Daily Pharma Scoop: Right Time To Buy Regeneron, Eli Lilly Gives Guidance, Bluebird Announces Offering (Seeking Alpha)
Related TEVA
Goldman Sachs: Now Is The Time To Get In On Teva's Turnaround
Benzinga's Top Upgrades, Downgrades For December 15, 2017
Teva launches generic Viread in U.S. (Seeking Alpha)

MediciNova, Inc. (NASDAQ: MNOV) shares climbed 22.51 percent to $4.30 in pre-market trading after the company reported the FDA approval of the second Phase 2 protocol for MN-001 in NASH which targets NASH patients with hypertriglyceridemia.

Allergan PLC (NYSE: AGN) shares rose 8.37 percent to $334.00 in pre-market trading after Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced its plans to buy Allergan's generic drugs unit for $40.5 billion in a cash and stock deal.

Perrigo Company plc Ordinary Shares (NYSE: PRGO) shares rose 4.41 percent to $194.73 in pre-market trading. Perrigo is expected to release Q2 results on August 5, 2015.

Central European Media Enterprises Ltd. (NASDAQ: CETV) shares climbed 4.10 percent to $2.03 in pre-market trading after dropping 0.51 percent on Friday.

Stratasys, Ltd. (NASDAQ: SSYS) gained 2.09 percent to $35.19 in pre-market trading. Dougherty & Company upgraded Stratasys to Buy

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers


Related Articles (CETV + AGN)

View Comments and Join the Discussion!

Partner Center